Get started
BIOSYENT INCBIOSYENT INCBIOSYENT INC

BIOSYENT INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RX chart


Full chart

RX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪117.58 M‬ CAD
Dividend yield (indicated)
1.80%
Price to earnings Ratio (TTM)
16.50
Basic EPS (TTM)
0.63 CAD
Net income (FY)
‪7.27 M‬ CAD
Revenue (FY)
‪35.03 M‬ CAD
Shares float
‪7.21 M‬
Beta (1Y)
0.33

About BIOSYENT INC


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
René C. Goehrum
Website
biosyent.com
Headquarters
Mississauga
Founded
1947
FIGI
BBG000BZ3YM7
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RX news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as RX.

Frequently Asked Questions


The current price of RX is 10.50 CAD — it has increased by 2.44% in the past 24 hours. Watch BIOSYENT INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange BIOSYENT INC stocks are traded under the ticker RX.
RX stock hasn't changed in a week, the month change is a −7.08% fall, over the last year BIOSYENT INC has showed a 23.53% increase.
We've gathered analysts' opinions on BIOSYENT INC future price: according to them, RX price has a max estimate of 11.75 CAD and a min estimate of 11.75 CAD. Watch RX chart and read a more detailed BIOSYENT INC stock forecast: see what analysts think of BIOSYENT INC and suggest that you do with its stocks.
RX reached its all-time high on Sep 19, 2014 with the price of 12.82 CAD, and its all-time low was 0.02 CAD and was reached on Nov 14, 2008. View more price dynamics on RX chart.
See other stocks reaching their highest and lowest prices.
RX stock is 3.01% volatile and has beta coefficient of 0.33. Track BIOSYENT INC stock price on the chart and check out the list of the most volatile stocks — is BIOSYENT INC there?
Today BIOSYENT INC has the market capitalization of ‪120.45 M‬, it has increased by 1.35% over the last week.
Yes, you can track BIOSYENT INC financials in yearly and quarterly reports right on TradingView.
BIOSYENT INC is going to release the next earnings report on May 23, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOSYENT INC revenue for the last quarter amounts to ‪8.80 M‬ CAD, despite the estimated figure of ‪9.10 M‬ CAD. In the next quarter, revenue is expected to reach ‪9.10 M‬ CAD.
RX net income for the last quarter is ‪1.61 M‬ CAD, while the quarter before that showed ‪2.31 M‬ CAD of net income which accounts for −30.10% change. Track more BIOSYENT INC financial stats to get the full picture.
Yes, RX dividends are paid quarterly. The last dividend per share was 0.050 CAD. As of today, Dividend Yield (TTM)% is 1.76%. Tracking BIOSYENT INC dividends might help you take more informed decisions.
BIOSYENT INC dividend yield was 1.68% in 2024, and payout ratio reached 29.49%. The year before the numbers were 1.79% and 30.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOSYENT INC EBITDA is ‪9.22 M‬ CAD, and current EBITDA margin is 26.33%. See more stats in BIOSYENT INC financial statements.
Like other stocks, RX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOSYENT INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOSYENT INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOSYENT INC stock shows the buy signal. See more of BIOSYENT INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.